- Report
- March 2025
- 2500 Pages +
Global
From €4546EUR$4,995USD£3,897GBP
- Report
- March 2025
- 143 Pages
Global
From €3185EUR$3,500USD£2,731GBP
- Newsletter
- April 2025
Global
€2726EUR$2,995USD£2,337GBP
- Report
- February 2024
- 442 Pages
Global
From €4232EUR$4,650USD£3,628GBP
- Report
- October 2023
- 130 Pages
Europe
From €3640EUR$4,000USD£3,121GBP
- Report
- October 2022
- 85 Pages
Europe
From €1365EUR$1,500USD£1,170GBP
- Book
- October 2013
- 488 Pages
- Book
- December 2013
- 720 Pages
- Book
- July 2024
- 256 Pages
- Book
- April 2024
- 304 Pages
Angiogenesis is a process in biotechnology that involves the growth of new blood vessels from existing vessels. It is a key factor in the development of many diseases, including cancer, diabetes, and cardiovascular diseases. It is also a key factor in wound healing and tissue regeneration.
Angiogenesis is a rapidly growing field of biotechnology, with many companies developing treatments and therapies to target the process. Companies are researching and developing drugs that target the growth of new blood vessels, as well as treatments that inhibit the growth of existing vessels. Additionally, companies are researching and developing gene therapies and stem cell therapies to target angiogenesis.
Some companies in the angiogenesis market include Regeneron Pharmaceuticals, Novartis, AstraZeneca, and Amgen. Show Less Read more
